Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome.
Acute coronary syndrome
Markov model
Mid-term cost-effectiveness
Person-centred care
Randomized-controlled trial
Journal
The European journal of health economics : HEPAC : health economics in prevention and care
ISSN: 1618-7601
Titre abrégé: Eur J Health Econ
Pays: Germany
ID NLM: 101134867
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
17
04
2020
accepted:
26
08
2020
pubmed:
9
9
2020
medline:
20
8
2021
entrez:
8
9
2020
Statut:
ppublish
Résumé
Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown. To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective. The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation. Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold). Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.
Sections du résumé
BACKGROUND
BACKGROUND
Person-centred care has been shown to be cost-effective compared to usual care for several diseases, including acute coronary syndrome, in a short-term time perspective (< 2 years). The cost-effectiveness of person-centred care in a longer time perspective is largely unknown.
OBJECTIVES
OBJECTIVE
To estimate the mid-term cost-effectiveness of person-centred care compared to usual care for patients (< 65) with acute coronary syndrome, using a 2-year and a 5-year time perspective.
METHODS
METHODS
The mid-term cost-effectiveness of person-centred care compared to usual care was estimated by projecting the outcomes observed in a randomized-controlled trial together with data from health registers and data from the scientific literature, 3 years beyond the 2-year follow-up, using the developed simulation model. Probabilistic sensitivity analyses were performed using Monte Carlo simulation.
RESULTS
RESULTS
Person-centred care entails lower costs and improved effectiveness as compared to usual care, for a 2-year time and a 5-year perspective. Monte Carlo simulations suggest that the likelihoods of the person-centred care being cost-effective compared to usual care were between 80 and 99% and between 75 and 90% for a 2-year and a 5-year time perspective (using a 500,000 SEK/QALY willingness-to-pay threshold).
CONCLUSIONS
CONCLUSIONS
Person-centred care was less costly and more effective compared to usual care in a 2-year and a 5-year time perspective for patients with acute coronary syndrome under the age of 65.
Identifiants
pubmed: 32895879
doi: 10.1007/s10198-020-01230-8
pii: 10.1007/s10198-020-01230-8
pmc: PMC7581585
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
1317-1327Subventions
Organisme : Strategiske Forskningsråd
ID : 2009-1088
Références
Value Health. 2015 Mar;18(2):161-72
pubmed: 25773551
Cardiovasc Res. 2017 Dec 1;113(14):1708-1718
pubmed: 29016754
Scand Cardiovasc J. 2010 Feb;44(1):59-64
pubmed: 19629851
J Occup Environ Med. 2011 Jan;53(1):2-7
pubmed: 21187788
Eur J Prev Cardiol. 2017 Feb;24(3):274-280
pubmed: 27856805
Annu Rev Public Health. 2002;23:377-401
pubmed: 11910068
Swiss Med Wkly. 2012 Aug 22;142:w13655
pubmed: 22915246
Health Policy. 2017 Feb;121(2):169-179
pubmed: 28062091
Clinicoecon Outcomes Res. 2014 Jan 24;6:49-62
pubmed: 24493930
Adv Ther. 2016 Sep;33(9):1600-11
pubmed: 27397588
Heart Lung Circ. 2015 Sep;24(9):860-8
pubmed: 25837019
Heart Lung Circ. 2019 Feb;28(2):245-256
pubmed: 29150157
Value Health Reg Issues. 2016 May;9:22-27
pubmed: 27881255
Health Econ. 1998 Dec;7(8):723-40
pubmed: 9890333
Am Heart J. 2001 Mar;141(3):478-84
pubmed: 11263449
BMC Public Health. 2006 Jan 27;6:18
pubmed: 16441887
Int J Cardiol. 2015;187:693-9
pubmed: 25919754
Heart Lung Circ. 2018 Jun;27(6):656-665
pubmed: 28716519
BMC Health Serv Res. 2015 Apr 22;15:173
pubmed: 25896804
J Med Econ. 2013;16(4):510-21
pubmed: 23339464
Support Care Cancer. 2019 May;27(5):1825-1834
pubmed: 30171334
J Occup Environ Med. 2013 Jul;55(7):761-7
pubmed: 23787565
Evid Based Complement Alternat Med. 2015;2015:639267
pubmed: 26495019
Eur J Cardiovasc Nurs. 2016 Apr;15(2):186-94
pubmed: 26701344
J Adv Nurs. 2009 Aug;65(8):1626-35
pubmed: 19493145
Arq Bras Cardiol. 2015 Jul;105(1):53-64
pubmed: 25993485
Am J Manag Care. 2009 Mar;15(2 Suppl):S36-41
pubmed: 19355807
Health Econ. 2015 Oct;24(10):1289-1301
pubmed: 25070495
Eur J Heart Fail. 2014 Oct;16(10):1142-51
pubmed: 25159126
Eur Heart J. 2010 Nov;31(22):2755-64
pubmed: 20805110
Eur Heart J. 2015 May 14;36(19):1163-70
pubmed: 25586123
Eur J Cardiovasc Nurs. 2011 Dec;10(4):248-51
pubmed: 21764386
High Blood Press Cardiovasc Prev. 2017 Mar;24(1):77-84
pubmed: 28181202
Rev Esp Cardiol (Engl Ed). 2016 Jan;69(1):11-8
pubmed: 26342640
Eur Heart J Acute Cardiovasc Care. 2019 Dec;8(8):727-737
pubmed: 28777005
Swiss Med Wkly. 2013 Sep 19;143:w13851
pubmed: 24089294
Eur J Health Econ. 2007 Mar;8(1):51-7
pubmed: 17186199
Cardiol Ther. 2015 Dec;4(2):131-53
pubmed: 26099515
Singapore Med J. 2013 Mar;54(3):169-75
pubmed: 23546032
Int J Cardiol. 2017 Dec 15;249:42-47
pubmed: 28893432
Heart. 2015 Jan;101(2):119-25
pubmed: 25227704
J Adv Nurs. 2001 Jun;34(6):787-94
pubmed: 11422549
Pharmacoecon Open. 2019 Dec;3(4):495-504
pubmed: 30825129
Eur J Cardiovasc Nurs. 2016 Jun;15(4):276-84
pubmed: 25595358
Pharmacoeconomics. 1998 Apr;13(4):397-409
pubmed: 10178664